Cutar zuciya

Daga Wikipedia, Insakulofidiya ta kyauta.
Jump to navigation Jump to search

Cutar zuciya (CVD) rukuni ne na cututtuka waɗanda suka haɗa da zuciya ko tasoshin jini.[1] CVD ya haɗa da cututtuka na jijiyoyin jini (CAD) irin su angina da infarction na zuciya (wanda aka fi sani da ciwon zuciya).[1] Sauran CVDs sun haɗa da bugun jini, raunin zuciya, cututtukan zuciya na hauhawar jini, cututtukan zuciya na rheumatic, cardiomyopathy, rhythms na zuciya mara kyau, cututtukan zuciya na haihuwa, cututtukan zuciya na valvular, carditis, aortic aneurysms, cututtukan jijiyoyin gefe, cututtukan thromboembolic, da thrombosis na venous.[1][2]

Hanyoyin da ke ciki sun bambanta dangane da cutar.[1] Cutar na jijiyoyin jini, bugun jini, da cututtukan jijiyoyin jini sun haɗa da atherosclerosis.[1] Ana iya haifar da haka ta hanyar hawan jini, shan taba, ciwon sukari mellitus, rashin motsa jiki, kiba, hawan jini, rashin abinci mai gina jiki, yawan shan barasa, da sauransu.[1] An kiyasta hawan jini ya kai kusan 13% na mutuwar CVD, yayin da taba ke da kashi 9%, ciwon sukari 6%, rashin motsa jiki 6% da kiba 5%.[1] Ciwon zuciya na rheumatic na iya biyo bayan strep makogwaro ba tare da magani ba.[1]

An kiyasta cewa har zuwa 90% na CVD na iya yin rigakafi.[3][4] Rigakafin CVD ya haɗa da haɓaka abubuwan haɗari ta hanyar: cin abinci lafiya, motsa jiki, guje wa hayakin taba da iyakance shan barasa.[1] Yin maganin abubuwan haɗari, kamar hawan jini, lipids na jini da ciwon sukari shima yana da fa'ida.[1] Yin maganin mutanen da ke da strep makogwaro tare da maganin rigakafi na iya rage haɗarin cututtukan zuciya na rheumatic.[5] Amfani da aspirin a cikin mutane, waɗanda ba su da lafiya, ba shi da fa'ida mara tabbas.[6][7]

Cututtukan zuciya da jijiyoyin jini sune kan gaba wajen mutuwa a duk sassan duniya in banda Afirka.[1] Tare CVD ya haifar da mutuwar mutane miliyan 17.9 (32.1%) a cikin 2015, daga 12.3 miliyan (25.8%) a cikin 1990.[8][2] Mutuwar, a wani shekaru da aka ba da, daga CVD ya fi kowa kuma yana karuwa a yawancin ƙasashe masu tasowa, yayin da rates ke karuwa. sun ragu a yawancin kasashen da suka ci gaba tun daga shekarun 1970.[9][10] Cututtukan jijiyoyin jini da bugun jini suna lissafin 80% na mutuwar CVD a cikin maza da 75% na mutuwar CVD a cikin mata.[1] Yawancin cututtukan zuciya da jijiyoyin jini suna shafar tsofaffi. A cikin Amurka 11% na mutane tsakanin 20 zuwa 40 suna da CVD, yayin da 37% tsakanin 40 da 60, 71% na mutane tsakanin 60 da 80, da 85% na mutane sama da 80 suna da CVD.[11] Matsakaicin shekarun mutuwa daga cututtukan jijiyoyin jini a cikin ƙasashen da suka ci gaba ya kai kusan 80 yayin da yake kusan 68 a ƙasashe masu tasowa.[12] Ganewar cututtuka yawanci yana faruwa shekaru bakwai zuwa goma a baya a cikin maza idan aka kwatanta da mata.[13]

Manazarta[gyara sashe | Gyara masomin]

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 Mendis, Shanthi; Puska, Pekka; Norrving, Bo (2011). Global Atlas on Cardiovascular Disease Prevention and Control (PDF). World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. pp. 3–18. ISBN 978-92-4-156437-3. Archived (PDF) from the original on 2014-08-17.
  2. 2.0 2.1 Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al. (GBD 2013 Mortality and Causes of Death Collaborators) (January 2015). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.
  3. McGill HC, McMahan CA, Gidding SS (March 2008). "Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study". Circulation. 117 (9): 1216–27. doi:10.1161/CIRCULATIONAHA.107.717033. PMID 18316498.
  4. O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. (August 2016). "Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study". Lancet. 388 (10046): 761–75. doi:10.1016/S0140-6736(16)30506-2. PMID 27431356.
  5. Spinks A, Glasziou PP, Del Mar CB (November 2013). "Antibiotics for sore throat". The Cochrane Database of Systematic Reviews. 11 (11): CD000023. doi:10.1002/14651858.CD000023.pub4. PMC 6457983. PMID 24190439.
  6. Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Ngianga-Bakwin K, et al. (2013). "Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials". PLOS ONE. 8 (12): e81970. Bibcode:2013PLoSO...881970S. doi:10.1371/journal.pone.0081970. PMC 3855368. PMID 24339983.
  7. Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, et al. (September 2013). "Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews". Health Technology Assessment. 17 (43): 1–253. doi:10.3310/hta17430. PMC 4781046. PMID 24074752.
  8. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
  9. Institute of Medicine of the National Academies (2010). "Epidemiology of Cardiovascular Disease". In Fuster, Valentin; Kelly, Bridget B. (eds.). Promoting cardiovascular health in the developing world : a critical challenge to achieve global health. Washington, DC: National Academies Press. ISBN 978-0-309-14774-3. Archived from the original on 2017-09-08.
  10. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M (April 2014). "Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study". Circulation. 129 (14): 1483–92. doi:10.1161/circulationaha.113.004042. PMC 4181359. PMID 24573352.
  11. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. (January 2013). "Heart disease and stroke statistics--2013 update: a report from the American Heart Association". Circulation. 127 (1): e6–e245. doi:10.1161/cir.0b013e31828124ad. PMC 5408511. PMID 23239837.
  12. Institute of Medicine of the National Academies (2010). "Epidemiology of Cardiovascular Disease". In Fuster, Valentin; Kelly, Bridget B. (eds.). Promoting cardiovascular health in the developing world : a critical challenge to achieve global health. Washington, DC: National Academies Press. ISBN 978-0-309-14774-3. Archived from the original on 2017-09-08.
  13. Mendis, Shanthi; Puska, Pekka; Norrving, Bo (2011). Global atlas on cardiovascular disease prevention and control (1 ed.). Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. p. 48. ISBN 978-92-4-156437-3.